Table 1. Demographic Data and Surgical Characteristics.
| Characteristic | Patients (n = 358 012), No. (%) | ||
|---|---|---|---|
| Received opioids | Did not receive opioids | Overall cohort | |
| Demographic | |||
| No. | 93 046 | 264 966 | 358 012 |
| Age, mean (SD), y | 65 (13) | 70 (12) | 69 (3) |
| Sex | |||
| Male | 51 369 (58.2) | 154 240 (55.2) | 205 609 (57.4) |
| Female | 41 668 (44.8) | 110 715 (41.8) | 142 383 (42.6) |
| Race and ethnicity | |||
| Asian | 718 (0.9) | 2059 (0.9) | 2777 (0.9) |
| Black | 4781 (5.8) | 7863 (3.5) | 12 644 (4.1) |
| Hispanic | 3220 (3.9) | 8815 (4.0) | 12 035 (3.9) |
| White | 74 343 (89.5) | 204 096 (91.6) | 278 439 (91.0) |
| Unknown | 9984 (10.7) | 42 133 (15.9) | 52 117 (14.6) |
| Information for patients with single-site MMS only | |||
| No. | 79 982 | 229 150 | 309 132 |
| Skin cancer type | |||
| BCC | 41 132 (51.4) | 124 765 (54.5) | 165 897 (53.7) |
| SCC | 15 091 (18.9) | 54 748 (23.9) | 69 839 (22.6) |
| SCCIS | 2316 (2.9) | 13 650 (6.0) | 15 966 (5.2) |
| MM | 500 (0.6) | 639 (0.3) | 1139 (0.4) |
| MIS | 306 (0.4) | 819 (0.4) | 1125 (0.4) |
| Unspecified | 20 621 (25.8) | 34 507 (15.1) | 55 128 (17.8) |
| MCC | 16 (0.02) | 22 (0.01) | 38 (0.01) |
| Tumor location | |||
| Face | 45 217 (56.5) | 132 544 (57.8) | 177 761 (57.5) |
| Scalp/neck | 7377 (9.2) | 25 173 (11.0) | 32 550 (10.5) |
| Ear | 7072 (8.8) | 19 202 (8.4) | 26 274 (8.5) |
| Eye | 4308 (5.4) | 6999 (3.0) | 11 307 (3.7) |
| Lip | 4233 (5.3) | 8163 (3.6) | 12 396 (4.0) |
| Trunk | 2182 (2.7) | 7183 (3.1) | 9365 (3.0) |
| Upper limb | 3474 (4.3) | 12 910 (5.6) | 16 384 (5.3) |
| Lower limb | 2676 (3.4) | 10 990 (4.8) | 13 666 (4.4) |
| Other | 3443 (4.3) | 5986 (2.6) | 9429 (3.1) |
Abbreviations: BCC, basal cell carcinoma; MCC, Merkel cell carcinoma; MIS, melanoma in situ; MM, malignant melanoma; MMS, Mohs micrographic surgery; SCC, squamous cell carcinoma; SCCIS, squamous cell carcinoma in situ.